Changing the tune: Plasticity and adaptation of retrograde signals

Trends in Neurosciences

Volumn 36, Issue 8, 2013, Pages 471-479

  Iremonger, Karl J ^a   Wamsteeker Cusulin, Jaclyn I ^b   Bains, Jaideep S ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Dendrite; Endocannabinoid; Metaplasticity; Plasticity; Retrograde; Synapse

Indexed keywords

CANNABINOID 1 RECEPTOR; ILLICIT DRUG;

ADAPTATION; DENDRITIC CELL; ENERGY BALANCE; GABAERGIC TRANSMISSION; HUMAN; IN VIVO STUDY; INFORMATION PROCESSING; INFORMATION STORAGE; LONG TERM POTENTIATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; SYNAPSE;

DENDRITE; ENDOCANNABINOID; METAPLASTICITY; PLASTICITY; RETROGRADE; SYNAPSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; MODELS, NEUROLOGICAL; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84881029519     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.04.007     Document Type: Review

References (107)

1. Regehr W.G., et al. Activity-dependent regulation of synapses by retrograde messengers. Neuron 2009, 63:154-170.
2. Ludwig M., Pittman Q.J. Talking back: dendritic neurotransmitter release. Trends Neurosci. 2003, 26:255-261.
3. Katona I., Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 2008, 14:923-930.
4. Kano M., et al. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
5. Ohno-Shosaku T., et al. Endocannabinoids and retrograde modulation of synaptic transmission. Neuroscientist 2012, 18:119-132.
6. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
7. Castillo P.E., et al. Endocannabinoid signaling and synaptic function. Neuron 2012, 76:70-81.
8. Alger B.E. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J. Physiol. 2012, 590:2203-2212.
9. Zilberter Y., et al. Dendritic release of retrograde messengers controls synaptic transmission in local neocortical networks. Neuroscientist 2005, 11:334-344.
10. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
11. Kreitzer A.C., Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci. 2001, 21:RC174.
12. Ohno-Shosaku T., et al. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
13. Tanimura A., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission. Neuron 2010, 65:320-327.
14. Gao Y., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30:2017-2024.
15. Maejima T., et al. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
16. Varma N., et al. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 2001, 21:RC188.
17. Kim J., et al. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 2002, 22:10182-10191.
18. Best A.R., Regehr W.G. Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J. Neurosci. 2008, 28:6508-6515.
19. Foldy C., et al. Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat. Neurosci. 2007, 10:1128-1130.
20. Haj-Dahmane S., Shen R.Y. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J. Neurosci. 2005, 25:896-905.
21. Kola B., et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 2008, 3:e1797.
22. Hirasawa M., et al. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J. Physiol. 2004, 559:611-624.
23. Zampronio A.R., et al. Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus. J. Neurosci. 2010, 30:16855-16863.
24. Maejima T., et al. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J. Neurosci. 2005, 25:6826-6835.
25. Hashimotodani Y., et al. Ca2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr. Opin. Neurobiol. 2007, 17:360-365.
26. Hashimotodani Y., et al. Phospholipase Cβ serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
27. Kreitzer A.C., Malenka R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci. 2005, 25:10537-10545.
28. Pan B., et al. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J. Neurosci. 2008, 28:1385-1397.
29. Yin H.H., Lovinger D.M. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8251-8256.
30. Kuzmiski J.B., et al. Metaplasticity of hypothalamic synapses following in vivo challenge. Neuron 2009, 62:839-849.
31. Calabresi P., et al. Postreceptor mechanisms underlying striatal long-term depression. J. Neurosci. 1994, 14:4871-4881.
32. Calabresi P., et al. Glutamate-Triggered Events Inducing Corticostriatal Long-Term Depression. J. Neurosci. 1999, 19:6102-6110.
33. Gerdeman G.L., et al. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 2002, 5:446-451.
34. Shen W.X., et al. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
35. Lerner T.N., Kreitzer A.C. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 2012, 73:347-359.
36. Huang J., et al. Inhibition of G alpha(q)-dependent PLC-beta 1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. Am. J. Physiol. 2007, 292:C200-C208.
37. Saugstad J.A., et al. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J. Neurosci. 1998, 18:905-913.
38. Wang Z.F., et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
39. Tozzi A., et al. The distinct role of medium spiny neurons and cholinergic interneurons in the D-2/A(2A) receptor interaction in the striatum: implications for Parkinson's disease. J. Neurosci. 2011, 31:1850-1862.
40. Mathur B.N., Lovinger D.M. Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front. Pharmacol. 2012, 3:66.
41. Chiu C.Q., et al. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 2010, 30:7236-7248.
42. Pan B., et al. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci. 2008, 28:14018-14030.
43. Hoffman A.F., et al. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci. 2010, 30:545-555.
44. Huang Y., et al. Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice. J. Neurosci. 2008, 28:7074-7083.
45. De Chiara V., et al. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J. Neurosci. 2010, 30:8127-8137.
46. Carey M.R., Regehr W.G. Noradrenergic control of associative synaptic plasticity by selective modulation of instructive signals. Neuron 2009, 62:112-122.
47. Zhu P.J., Lovinger D.M. Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J. Neurophysiol. 2007, 97:4386-4389.
48. Chen K., et al. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 2007, 27:46-58.
49. Edwards D.A., et al. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8142-8147.
50. Adermark L., Lovinger D.M. Frequency-dependent inversion of net striatal output by endocannabinoid-dependent plasticity at different synaptic inputs. J. Neurosci. 2009, 29:1375-1380.
51. Adermark L., et al. Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur. J. Neurosci. 2009, 29:32-41.
52. Singla S., et al. Mechanisms for synapse specificity during striatal long-term depression. J. Neurosci. 2007, 27:5260-5264.
53. Varma N., et al. Presynaptic factors in the regulation of DST expression in hippocampus. Neuropharmacology 2002, 43:550-562.
54. Lourenco J., et al. Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. Nat. Neurosci. 2010, 13:197-204.
55. Foldy C., et al. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J. Neurosci. 2006, 26:1465-1469.
56. Heifets B.D., et al. Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10250-10255.
57. Chen K., et al. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 2003, 39:599-611.
58. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat. Neurosci. 2010, 13:592-600.
59. Duguid I.C., Smart T.G. Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses. Nat. Neurosci. 2004, 7:525-533.
60. Harkany T., et al. Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3. J. Neurosci. 2004, 24:4978-4988.
61. Di S., et al. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J. Neurosci. 2009, 29:393-401.
62. Oliet S.H., et al. Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J. Neurosci. 2007, 27:1325-1333.
63. Bains J.S., Ferguson A.V. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurones of the rat paraventricular nucleus. J. Physiol. 1997, 499(Pt 3):733-746.
64. Brown C.H., et al. kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo. J. Neurosci. 1998, 18:9480-9488.
65. Iremonger K.J., Bains J.S. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus. J. Neurosci. 2009, 29:7349-7358.
66. Ludwig M., et al. Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites. Nature 2002, 418:85-89.
67. Wamsteeker Cusulin J.I., et al. Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses. Nat. Neurosci. 2013, 16:596-604.
68. Wamsteeker J.I., et al. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2010, 30:11188-11196.
69. Nugent F.S., et al. Opioids block long-term potentiation of inhibitory synapses. Nature 2007, 446:1086-1090.
70. Crosby K.M., et al. Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron 2011, 71:529-541.
71. Bonfardin V.D., et al. Kainate receptor-induced retrograde inhibition of glutamatergic transmission in vasopressin neurons. J. Neurosci. 2012, 32:1301-1310.
72. Iremonger K.J., et al. Dual regulation of anterograde and retrograde transmission by endocannabinoids. J. Neurosci. 2011, 31:12011-12020.
73. Kyriakatos A., El Manira A. Long-term plasticity of the spinal locomotor circuitry mediated by endocannabinoid and nitric oxide signaling. J. Neurosci. 2007, 27:12664-12674.
74. Makara J.K., et al. Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J. Neurosci. 2007, 27:10211-10222.
75. Safo P.K., Regehr W.G. Endocannabinoids control the induction of cerebellar LTD. Neuron 2005, 48:647-659.
76. Duguid I.C., et al. Somatodendritic release of glutamate regulates synaptic inhibition in cerebellar Purkinje cells via autocrine mGluR1 activation. J. Neurosci. 2007, 27:12464-12474.
77. Mato S., et al. A single in-vivo exposure to delta9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 2004, 7:585-586.
78. Hoffman A.F., et al. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 2003, 23:4815-4820.
79. Nazzaro C., et al. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat. Neurosci. 2012, 15:284-293.
80. Mato S., et al. Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. J. Neurosci. 2005, 25:11619-11627.
81. Williams J.T., et al. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 2001, 81:299-343.
82. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
83. Fourgeaud L., et al. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J. Neurosci. 2004, 24:6939-6945.
84. Centonze D., et al. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology 2004, 29:1488-1497.
85. Centonze D., et al. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur. J. Neurosci. 2007, 25:1631-1640.
86. Guan Y.Z., Ye J.H. Ethanol blocks long-term potentiation of gabaergic synapses in the ventral tegmental area involving μ-opioid receptors. Neuropsychopharmacology 2010, 35:1841-1849.
87. Niehaus J.L., et al. Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area. Eur. J. Neurosci. 2010, 32:108-117.
88. Graziane N.M., et al. Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron 2013, 77:942-954.
89. Kuzmiski J.B., et al. Stress-induced priming of glutamate synapses unmasks associative short-term plasticity. Nat. Neurosci. 2010, 13:1257-1264.
90. Wang M.N., et al. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J. Psychopharmacol. 2012, 26:56-70.
91. Ni Y.G., et al. Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J. Neurosci. 1999, 19:3674-3680.
92. Kim G., et al. Acute stress responsive RGS proteins in the mouse brain. Mol. Cells 2010, 30:161-165.
93. Gold S.J., et al. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 1997, 17:8024-8037.
94. Patel S., et al. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
95. Sumislawski J.J., et al. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 2011, 36:2750-2761.
96. Labouebe G., et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat. Neurosci. 2013, 16:300-308.
97. Jo Y.H., et al. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 2005, 48:1055-1066.
98. Massa F., et al. Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J. Neurosci. 2010, 30:6273-6281.
99. Rossi S., et al. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J. Neurosci. 2008, 28:7284-7292.
100. Wang W., et al. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010, 35:2249-2261.
101. Lafourcade M., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14:345-350.
102. Rossi S., et al. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010, 11:83-90.
103. Chiodi V., et al. Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2012, 45:983-991.
104. Blazquez C., et al. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain 2011, 134:119-136.
105. Rossi S., et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2011, 25:947-956.
106. Castelli M., et al. Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter. Eur. J. Neurosci. 2011, 34:1369-1377.
107. Lichtman A.H., et al. Endocannabinoid overload. Mol. Pharmacol. 2010, 78:993-995.